Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on September 19, 2007, to report a significant governance change approved by its Board of Directors on September 17, 2007. The company amended its bylaws to implement a majority voting standard for uncontested director elections. This change means that for directors not facing opposition, a majority of the votes cast will be required for election, rather than a plurality. This move reflects a commitment to enhanced corporate governance and shareholder rights, aligning the company with evolving best practices in director accountability.
Key Highlights
- 1Edwards Lifesciences amended its bylaws on September 17, 2007.
- 2The amendment implements a majority voting standard for director elections.
- 3This change applies to uncontested director elections.
- 4A majority of votes cast will be required for election in uncontested scenarios.
- 5This action enhances corporate governance practices.
- 6The amendment aims to increase director accountability to shareholders.
Frequently Asked Questions
The primary change is the amendment of Edwards Lifesciences' bylaws to adopt a majority voting standard for uncontested director elections. This means that for directors who are not opposed by other candidates, they must receive more 'for' votes than 'against' votes to be elected.
The Board of Directors voted to amend the bylaws on September 17, 2007, and the amended and restated Bylaws are dated as of that date. The 8-K was filed on September 19, 2007.
This change empowers shareholders by requiring directors in uncontested elections to secure a majority of the votes cast. It provides a clearer mechanism for shareholders to express their confidence (or lack thereof) in director nominees.
No, the filing specifically states that the majority voting standard is for 'uncontested director elections'. In a contested election where multiple candidates vie for a single seat, the rules may differ.